by Georgi Ivanov | Sep 20, 2024 | Blog
Immunotherapies were back in the spotlight at the European Society for Medical Oncology’s congress this year, but its limitations are prompting a strategic realignment. Back in style Our analysis of last year’s ESMO congress discovered a notable focus on...
by Commetric | Jan 20, 2023 | Blog
The annual healthcare takeover of San Francisco is arguably still the most influential gathering in the business, as it generally sets the tone for the year for the drug industry. Our media analysis found that despite a slowdown, M&A still gives pharma brands a PR...
by Commetric | Aug 13, 2021 | Blog
While pharma companies experienced reputational boosts thanks to the rapid vaccine development, they are now facing increasing pressure to introduce new Covid treatments, as more and more experts assert that vaccination alone won’t be enough to handle the...
by Commetric | Jul 23, 2021 | Blog
The pandemic put mRNA in the media spotlight, with many stories reporting that the novel technology could be used beyond Covid. Our analysis found that mRNA’s success seen with Pfizer and Moderna has started to change the conversation around diseases such as...
